Armistice Capital, LLC Alkermes Plc. Transaction History

Armistice Capital, LLC

$6.02 Billion
Q3 2024

A detailed history of Armistice Capital, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Armistice Capital, LLC holds 1,448,654 shares of ALKS stock, worth $40.4 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

1,448,654

Previous 2,699,179 46.33%

Holding current value

$40.4 Million

Previous $65.1 Million 37.67%

% of portfolio

0.67%

Previous 0.85%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.01 - $28.55 $28.8 Million - $35.7 Million	-1,250,525 Reduced 46.33%	1,448,654 $40.5 Million
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $47 Million - $55.2 Million	2,026,961 Added 301.53%	2,699,179 $65.1 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $13.9 Million - $17.2 Million	-527,782 Reduced 43.98%	672,218 $18.2 Million
Q4 2023 Feb 13, 2024	SELL	$23.37 - $28.68 $16.3 Million - $20 Million	-696,775 Reduced 36.73%	1,200,000 $33.3 Million
Q3 2023 Nov 14, 2023	SELL	$27.17 - $31.97 $2.8 Million - $3.3 Million	-103,225 Reduced 5.16%	1,896,775 $53.1 Million
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $20.5 Million - $24.3 Million	-724,000 Reduced 26.58%	2,000,000 $62.6 Million
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $4.45 Million - $5.11 Million	-176,000 Reduced 6.07%	2,724,000 $76.8 Million
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $19.6 Million - $23.4 Million	-892,000 Reduced 23.52%	2,900,000 $75.8 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $19.1 Million - $27.7 Million	868,000 Added 29.69%	3,792,000 $84.7 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $29 Million - $33.6 Million	1,100,000 Added 60.31%	2,924,000 $87.1 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $31.1 Million - $37.7 Million	-1,348,000 Reduced 42.5%	1,824,000 $48 Million
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $17.5 Million - $26.2 Million	816,000 Added 34.63%	3,172,000 $73.8 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $36.1 Million - $49.6 Million	-1,544,000 Reduced 39.59%	2,356,000 $72.7 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $7.06 Million - $9.46 Million	376,000 Added 10.67%	3,900,000 $95.6 Million
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $23.8 Million - $30.3 Million	1,308,000 Added 59.03%	3,524,000 $65.8 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $1.42 Million - $2.03 Million	92,000 Added 4.33%	2,216,000 $44.2 Million
Q3 2020 Nov 16, 2020	BUY	$16.16 - $20.66 $34.3 Million - $43.9 Million	2,124,000 New	2,124,000 $35.2 Million

Others Institutions Holding ALKS

# of Institutions

361

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.58B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account

Armistice Capital, LLC Alkermes Plc. Transaction History